Incyte and Agenus Amend Collaboration Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Incyte (INCY) PT Raised to $140 at Jefferies on 4Q Report, Jakafi Metrics
February 15, 2017 8:10 AM ESTJefferies analyst Brian Abrahams reiterates Buy rating and raises price target on Incyte Corp. (NASDAQ: INCY) to $140 (from $136) as the company delivered in-line Jakafi sales figures, while offering positive guidance.
Abrahams comments, "Solid, unsurprising Valentine's Day 4Q report, with good Jakafi metrics and... More
RBC Capital Reiterates Outperform Rating on Incyte (INCY) Following 4Q Results
February 14, 2017 9:37 AM ESTRBC Capital Markets analyst Simos Simeonidis reiterates Outperform rating on Incyte Corporation (NASDAQ: INCY) suggesting Jakafi continues to grow, despite the company reporting 2016 fourth quarter revenues below consensus.
Simeonidis comments, INCY reported slightly below consensus Jakafi/total revenue numbers, despite decent growth five years... More
